INS and type 1 diabetes mellitus: Insulin, a therapeutic peptide used to treat Type I diabetes, interacts with polymers commonly found in healthcare settings <i>via</i> various hydrophobic interactions, which can trigger insulin agglomeration, thereby reducing its bioavailability and therapeutic efficacy.